Specifically, FGF1, FGF2, FGF receptor (FGFR) 2 and FGFR3 were down-regulated in the frontal cortex of MDD patients, which strongly suggests that FGF signaling must be disrupted in mood disorders [2, 3]. The gene discussed is FGFR3; the disease is mood disorder.